Browse by author
Lookup NU author(s): Dr Clive Ballard, Professor John O'Brien, Dr Christopher Morris, Dr Robert Barber, Dr Alan Swann, Dr David Neill, Professor Ian McKeith
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Background: Little is known about the rate of progression or associations of cognitive impairment in dementia with Lewy bodies (DLB), or the associations of accelerated decline. Method: Dementia patients from a case register were evaluated at baseline and 1 year follow-up using the Cambridge Assessment for Mental Disorders in the Elderly, section B (CAMCOG) and the Mini-Mental State Examination (MMSE) to determine the rate of cognitive decline. Operationalized clinical diagnoses were applied (NINCDS ADRDA for Alzheimer's disease (AD), NINCDS AIRENS for vascular dementia (VaD) and consensus criteria for DLB). Results: One hundred and ninety-three patients completed annual MMSE schedules (AD, 101; DLB, 64; VaD, 38), of whom 154 completed the CAMCOG. The magnitude of cognitive decline (MMSE, 4-5 points; CAMCOG, 12-14 points) was similar in each of the dementias. The strongest predictor of accelerated cognitive decline in DLB was the apolipoprotein E4 allele (17.5 vs 8.3 points decline on the CAMCOG). Conclusion: Over 1 year, DLB, VaD and AD patients had similar rates of cognitive decline overall. Apolipoprotein E4 may be an important predictor or more rapid decline in DLB. Copyright © 2001 John Wiley & Sons, Ltd.
Author(s): McKeith I; Morris CM; O'Brien J; Barber R; Ballard C; Swann A; Neill D
Publication type: Article
Publication status: Published
Journal: International Journal of Geriatric Psychiatry
Year: 2001
Volume: 16
Issue: 5
Pages: 499-503
ISSN (print): 0885-6230
ISSN (electronic): 1099-1166
Publisher: John Wiley & Sons
URL: http://dx.doi.org/10.1002/gps.381
DOI: 10.1002/gps.381
PubMed id: 11376466
Altmetrics provided by Altmetric
